Latest Asx Listing Rules News

Bendigo and Adelaide Bank clarifies a modest 5.8% variance in half-year cash earnings against market forecasts, confirming no material surprise and compliance with ASX disclosure rules.

Cardiex Limited has confirmed to the ASX that it holds no undisclosed information explaining the recent spike in its share price, affirming full compliance with continuous disclosure rules.

Superior Resources Limited issues a clarification on its Halls Reward Cu-Au-Ag Mine announcement, addressing compliance gaps while underscoring promising high-grade copper, gold, and silver targets revealed through historical data and ongoing exploration.

Future Metals NL has addressed an ASX price query by confirming the release of drilling results from its Eileen Bore Prospect, attributing recent trading activity to investor anticipation and compliance with disclosure rules.

Mont Royal Resources has voluntarily suspended its shares on the ASX pending a critical announcement about a proposed re-compliance transaction, signaling a pivotal moment for the mining company.

NeuRizer Ltd has completed a $200,000 private share placement, issuing over 133 million new shares to support working capital and advance its Urea Project.

Toys"R"Us ANZ has entered a strategic three-year partnership with Directed Electronics Australia to co-develop private label products and enhance marketing capabilities, marking a pivotal step in its growth strategy.

Acorn Capital Investment Fund Limited has been suspended from ASX trading due to a delayed periodic report, raising questions about its compliance and investor transparency.

Whitebark Energy Limited has issued a supplementary bidder's statement updating its $3 million capital raising and correcting share valuation details in its ongoing takeover offer for King Energy Limited.

Carly Holdings Limited has agreed to merge its car subscription operations with Carbar Holdings in a $3.8 million deal, aiming to create a larger, more competitive player in Australia’s growing car subscription sector.

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Laramide Resources Ltd. has acknowledged a delayed filing of a director's interest notice due to internal illness, prompting an ASX inquiry and procedural upgrades to prevent future lapses.